Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Lymphoid 1Dermatologic 1

Conditions

Mucositis 44Obesity 23Neoplasms 19Head and Neck Neoplasms 15Stomatitis 12Dyspnea 12Constipation 10Sexual Dysfunction, Physiological 8Squamous Cell Carcinoma of Head and Neck 7Breast Neoplasms 7Overweight 6Xerostomia 5Prostatic Neoplasms 5Radiation Injuries 4Opioid-Induced Constipation 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 3Pain 3Nausea 3Mouth Neoplasms 3Hematologic Neoplasms 3Colorectal Neoplasms 3Tongue Neoplasms 2Salivary Gland Neoplasms 2Multiple Myeloma 2Mouth Diseases 2Leukemia 2Intestinal Diseases 2Infertility 2Febrile Neutropenia 2

Interventions

fish oil triglycerides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Colitis × Other × Clear all
NCT00533078 2015-07-23

LUNCH1

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed
14 enrolled
Other

Colitis, Hyperphagia, Infections, Neutropenia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡